This trial is active, not recruiting.

Conditions acute, eosinophilic pneumonia
Sponsor Seoul National University Bundang Hospital
Start date July 2010
End date April 2011
Trial size 50 participants
Trial identifier NCT01152424, FeNO in AEP


Acute eosinophilic pneumonia (AEP) is diagnosed by cell count analysis of bronchoalveolar lavage fluid. However, the performance of bronchoscopy is not easy for patients with AEP, because they usually have hypoxia. Exhaled nitric oxide (FeNO) is usually elevated in the patients with eosinophilic inflammation such as asthma, but there is no previous studies FeNO in the patients with AEP. Investigators hypothesized that FeNO elevated significantly in patients with AEP, and FeNO can be used as non-invasive diagnostic method in patients who are clinically suspected with AEP, especially when the performance of bronchoscopy is difficult.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case control
Time perspective prospective

Primary Outcomes

The difference of FeNO in AEP and Community Acquired Pneumonia
time frame: Six months

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - All patients who visited the study hospital with bilateral pneumonic infiltration. Exclusion Criteria: - Patients who do not agree with our study protocol

Additional Information

Official title Usefulness of Exhaled NO in the Differential Diagnosis Acute Eosinophilic Pneumonia and Community Acquired Pneumonia
Trial information was received from ClinicalTrials.gov and was last updated in June 2011.
Information provided to ClinicalTrials.gov by Seoul National University Bundang Hospital.